[Federal Register Volume 86, Number 118 (Wednesday, June 23, 2021)]
[Notices]
[Pages 32934-32935]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13119]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control, (BSC, NCIPC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
National Center for Injury Prevention and Control (BSC, NCIPC). This 
meeting is partially open to the public. There will be 15 minutes 
allotted for public comments at the end of the open session from 11:40 
a.m., to 11:55 p.m., EDT.

DATES: The meeting will be held on July 29, 2021, from 10:00 a.m. to 
12:00 p.m., EDT (OPEN); and from 12:30 p.m., to 4:15 p.m., EDT 
(CLOSED).

ADDRESSES: Open Session: Webinar, Atlanta, Georgia. All participants 
must register using the link provided to attend the open meeting: 
https://dceproductions.zoom.us/webinar/register/wn_cz3nu0zfsg29fiojefau8q.
    Closed Session: Teleconference.

FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., 
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 
Buford Highway NE, Mailstop S106-9, Atlanta,

[[Page 32935]]

GA 30341, Telephone: (770) 488-3953; Email: [email protected].

SUPPLEMENTARY INFORMATION: Portions of the meeting as designated above 
will be closed to the public in accordance with provisions set forth in 
Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of 
the Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, CDC, pursuant to Public Law 92-463 (5 U.S.C. App.).
    Purpose: The Board will: (1) Conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to 
the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases, and other impairments; (2) assist States and their 
political subdivisions in preventing and suppressing communicable and 
non-communicable diseases and other preventable conditions and in 
promoting health and well-being; and (3) conduct and assist in research 
and control activities related to injury. The BSC, NCIPC makes 
recommendations regarding policies, strategies, objectives, and 
priorities; reviews progress toward injury prevention goals; and 
provides evidence in injury prevention-related research and programs. 
The Board also provides advice on the appropriate balance of intramural 
and extramural research, and the structure, progress, and performance 
of intramural programs. The Board is designed to provide guidance on 
extramural scientific program matters, including the: (1) Review of 
extramural research concepts for funding opportunity announcements; (2) 
conduct of Secondary Peer Review of extramural research grants, 
cooperative agreements, and contracts applications received in response 
to funding opportunity announcements as they relate to the Center's 
programmatic balance and mission; (3) submission of secondary review 
recommendations to the Center Director of applications to be considered 
for funding support; (4) review of research portfolios, and (5) review 
of program proposals.
    Matters To Be Considered: The open portion of the agenda will 
include discussion on NCIPC Research Priorities for Addressing Adverse 
Childhood Experiences. The closed portion of the agenda will focus on 
the Secondary Peer Review of extramural research grant applications 
received in response to three Notice of Funding Opportunities (NOFOs): 
(1) RFA-CE-21-001--``Rigorous Evaluation of Policies for their Impacts 
on the Primary Prevention of Multiple Forms of Violence''; (2) RFA-CE-
21-003--``Grants to Support New Investigators in Conducting Research 
Related to Preventing Interpersonal Violence Impacting Children and 
Youth''; and (3) RFA-CE-21-004--``Research Grants for Preventing 
Violence and Violence-Related Injury (R01)''; as well as PHS 2020 
Omnibus Solicitation of the NIH, CDC and FDA for Small Business 
Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical 
Trial Not Allowed). Agenda items are subject to change as priorities 
dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-13119 Filed 6-22-21; 8:45 am]
BILLING CODE 4163-18-P